Exercise for Parkinson's Disease
(HI-LITE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
Veterans with mid to later stage Parkinson's disease (PD) may not be able to work out as hard as they need to, to prevent brain cell loss. Maybe they could work out longer and more frequently to make up for this during their good times and good weeks and then rest during the bad weeks. The investigators will compare how effective working out a lot one week per month with a break of three weeks is to continuously exercising weekly with no breaks in people with mid stage PD. The investigators will look at how fast participants walk per minute, whether they become more physically active, the biochemicals in their blood, and at how stiff their blood vessels are before and after the exercise.
Will I have to stop taking my current medications?
The trial requires participants to be observed while not taking their antiparkinsonian medications to avoid certain side effects and fluctuations. This means you will need to stop these medications during specific observation periods.
Is exercise, including dance and walking, safe for people with Parkinson's disease?
How does the HV-PDAE and MV-PDAE treatment for Parkinson's disease differ from other treatments?
The HV-PDAE and MV-PDAE treatments are unique because they involve partnered dance aerobic exercise, which combines physical activity with social interaction, potentially improving both physical and mental health. This approach is different from traditional exercise or medication as it may enhance movement initiation and aerobic capacity, offering a novel way to address motor impairments in Parkinson's disease.13678
What data supports the effectiveness of the treatment HV-PDAE, MV-PDAE, and MV-WALK for Parkinson's Disease?
Who Is on the Research Team?
Madeleine E. Hackney, PhD
Principal Investigator
Atlanta VA Medical and Rehab Center, Decatur, GA
Are You a Good Fit for This Trial?
This trial is for veterans over 40 with moderate Parkinson's disease (stages 2 to 3), who can walk at least 10 feet and have a certain level of cognitive function. They must not have severe depression, major psychiatric illness, significant hearing loss, or serious heart conditions. Participants should benefit from Parkinson's medication and be able to commit to the study duration without long absences.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in Partnered Dance Aerobic Exercise (PDAE) or Walking for 52 weeks, with varying frequency and duration based on group assignment
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- HV-PDAE: High Volume Partnered Dance Aerobic Exercise
- MV-PDAE: Moderate Volume Partnered Dance Aerobic Exercise
- MV-WALK: Moderate Volume Walking
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor